Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas.

Blood - 15 Jul 1990

Vose J M, Peterson C, Bierman P J, Weisenburger D D, Linder J, Harrington D, Vaughan W P, Kessinger A, Armitage J O

Abstract excerpt

Advanced T-cell non-Hodgkin's lymphoma in adults has been found to have a poor outlook with conventional chemotherapy. To see if this extends to patients treated with high dose therapy and autologous hematopoietic stem cell transplantation, we reviewed the results with this treatment approach at our institution. From October, 1983, to May, 1988, 41 patients who underwent high-dose therapy and autologous...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Antigens, Surface

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Antineoplastic Agents

Share to B-Lymphocytes

Share to Bone Marrow Transplantation

Share to Phenotype

Share to Prognosis

Share to T-Lymphocytes

Source

Identifiers

PMID: 1973361

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas.PMID 1973361Read ↗

Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors.Semantic proximity Read ↗

Allogeneic Hematopoietic Stem Cell Transplantation for Peripheral T Cell Lymphomas; Evidence of Graft-Versus-T Cell Lymphoma EffectSemantic proximity Read ↗

What is the role of autologous transplant for lymphoma in the current era?Semantic proximity Read ↗

T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications.Semantic proximity Read ↗

Autologous bone marrow transplantation for progressive non-Hodgkin's lymphoma: clinical impact of immunophenotype and in vitro purging.Semantic proximity Read ↗

Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin LymphomaSemantic proximity Read ↗

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia.Semantic proximity Read ↗

Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with LymphomaSemantic proximity Read ↗

Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in JapanSemantic proximity Read ↗

Myeloablative vs reduced intensity T-cell–replete haploidentical transplantation for hematologic malignancySemantic proximity Read ↗

Multiple infusions of CD20-targeted T cells and low-dose IL-2 after SCT for high-risk non-Hodgkin's lymphoma: a pilot study.Semantic proximity Read ↗

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.